Literature DB >> 17582236

Determination and pharmacokinetic comparison of rhein in rats after oral dosed with Da-Cheng-Qi decoction and Xiao-Cheng-Qi decoction.

Wen-Fu Tang1, Xi Huang, Qin Yu, Feng Qin, Mei-Hua Wan, Yong-Gang Wang, Mao-Zhi Liang.   

Abstract

Da-Cheng-Qi decoction (DCQD) is composed of dahuang, houpu, zhishi and mangxiao, while Xiao-Cheng-Qi decoction (XCQD) just contains dahuang, houpu, and zhishi. A validated high-performance liquid chromatographic (HPLC) method was developed for the determination and pharmacokinetic comparison of rhein in rats. It was performed on a reversed-phase C(18) column (150 x 4.6 mm) with a mobile phase of methanol and 0.2% acetic acid (89:11, v/v) and ultraviolet detection at 254 nm. The assay was linear over the range 30-3000 ng/mL (r(2) = 0.9991), with mean percentage recovery of 101.4%. The RSD of intra- and inter-day precision were less than 3.0%, with accuracy in the range 96.8-102.5% for each of the concentrations tested. Following oral administration, rhein plasma levels revealed curves characterized by peaks at 20.5 and 30.1 min corresponding to dosages of 15 mg/kg (XCQD) and 20 mg/kg (DCQD) at mean concentrations of 1184.67 and 1814.27 ng/mL, respectively. The half-lives of rhein from XCQD and DCQD were 45.3 and 139.6 min, respectively. AUC(0-12h) of rhein after oral dosage with XCQD and DCQD were 3435.68 and 5382.25 microg/L h, respectively. The pharmacokinetic parameters may be used to guide the clinical prescription compatibility of traditional Chinese prescriptions related to dahuang and mangxiao. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17582236     DOI: 10.1002/bmc.873

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  6 in total

1.  Effect of formula compatibility on the pharmacokinetics of components from Dachengqi Decoction [See Text] in rats.

Authors:  Han-Lin Gong; Wen-Fu Tang; Jia Wang; Guang-Yuan Chen; Xi Huang
Journal:  Chin J Integr Med       Date:  2012-08-31       Impact factor: 1.978

2.  Effect of severe acute pancreatitis on pharmacokinetics of Da-Cheng-Qi Decoction components.

Authors:  Han-Lin Gong; Wen-Fu Tang; Qin Yu; Jin Xiang; Qing Xia; Guang-Yuan Chen; Xi Huang; Mao-Zhi Liang
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

3.  Effects of Chai-Qin-Cheng-Qi Decoction on cefotaxime in rats with acute necrotizing pancreatitis.

Authors:  Li-Hui Deng; Da-Kai Xiang; Ping Xue; Hai-Yan Zhang; Lei Huang; Qing Xia
Journal:  World J Gastroenterol       Date:  2009-09-21       Impact factor: 5.742

4.  Amelioration of experimental acute pancreatitis with Dachengqi Decoction via regulation of necrosis-apoptosis switch in the pancreatic acinar cell.

Authors:  Jia Wang; Guangyuan Chen; Hanlin Gong; Wei Huang; Dan Long; Wenfu Tang
Journal:  PLoS One       Date:  2012-07-02       Impact factor: 3.240

5.  Optimal timing for the oral administration of Da-Cheng-Qi decoction based on the pharmacokinetic and pharmacodynamic targeting of the pancreas in rats with acute pancreatitis.

Authors:  Yu-Mei Zhang; Lin Zhu; Xian-Lin Zhao; Huan Chen; Hong-Xin Kang; Jian-Lei Zhao; Mei-Hua Wan; Juan Li; Lv Zhu; Wen-Fu Tang
Journal:  World J Gastroenterol       Date:  2017-10-21       Impact factor: 5.742

6.  Formula Compatibility Identification of Dachengqi Decoction Based on the Effects of Absorbed Components in Cerulein-Injured Pancreatic AR42J Cells.

Authors:  Yumei Zhang; Lin Zhu; Jia Wang; Jianlei Zhao; Xianlin Zhao; Hui Guo; Juan Li; Wenfu Tang
Journal:  Evid Based Complement Alternat Med       Date:  2016-03-31       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.